Baillie Gifford & Co’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Baillie Gifford & Co's TWST Position: Q2 2026 in Review
Baillie Gifford & Co reduced its Twist Bioscience (TWST) stake by 11% in Q2 2026, selling an estimated $8.35M and leaving 1,086,779 shares worth $112M. The position accounts for 0.1% of the portfolio, ranked #127.
Baillie Gifford & Co first reported a position in TWST in Q3 2022 and has held it in 16 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Baillie Gifford & Co held 1,086,779 shares of Twist Bioscience worth $112M as of Q2 2026.
- Baillie Gifford & Co sold 128,372 Twist Bioscience shares in Q2 2026, an estimated $8.35M.
- Twist Bioscience made up 0.1% of Baillie Gifford & Co's portfolio in Q2 2026, its #127 holding.
- Baillie Gifford & Co first reported a position in Twist Bioscience in Q3 2022 and has held it in 16 quarters since.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.